HK1179626A1 - Process for the preparation of nebivolol - Google Patents

Process for the preparation of nebivolol

Info

Publication number
HK1179626A1
HK1179626A1 HK13107005.3A HK13107005A HK1179626A1 HK 1179626 A1 HK1179626 A1 HK 1179626A1 HK 13107005 A HK13107005 A HK 13107005A HK 1179626 A1 HK1179626 A1 HK 1179626A1
Authority
HK
Hong Kong
Prior art keywords
nebivolol
preparation
Prior art date
Application number
HK13107005.3A
Other languages
English (en)
Inventor
Sandra Bartoli
Amalia Cipollone
Daniela Fattori
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of HK1179626A1 publication Critical patent/HK1179626A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Peptides Or Proteins (AREA)
  • Treating Waste Gases (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK13107005.3A 2010-02-11 2013-06-14 Process for the preparation of nebivolol HK1179626A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2010A000053A IT1397962B1 (it) 2010-02-11 2010-02-11 Processo per la preparazione del nebivololo.
PCT/EP2011/051876 WO2011098474A1 (en) 2010-02-11 2011-02-09 Process for the preparation of nebivolol

Publications (1)

Publication Number Publication Date
HK1179626A1 true HK1179626A1 (en) 2013-10-04

Family

ID=42289104

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107005.3A HK1179626A1 (en) 2010-02-11 2013-06-14 Process for the preparation of nebivolol

Country Status (22)

Country Link
US (1) US8487122B2 (es)
EP (1) EP2534142B1 (es)
JP (1) JP5698266B2 (es)
KR (1) KR101726468B1 (es)
CN (1) CN102858759B (es)
AR (1) AR080149A1 (es)
AU (1) AU2011214396B2 (es)
BR (1) BR112012020252B8 (es)
CA (1) CA2786833C (es)
EA (1) EA019691B1 (es)
ES (1) ES2445543T3 (es)
HK (1) HK1179626A1 (es)
HR (1) HRP20140155T1 (es)
IL (1) IL220846A (es)
IT (1) IT1397962B1 (es)
MX (1) MX2012009386A (es)
PL (1) PL2534142T3 (es)
PT (1) PT2534142E (es)
RS (1) RS53134B (es)
SG (1) SG183266A1 (es)
WO (1) WO2011098474A1 (es)
ZA (1) ZA201206221B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8785664B2 (en) * 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
CN104650022B (zh) * 2013-11-20 2018-09-25 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
MX354930B (es) * 2014-10-23 2018-03-20 Consorcio Comex S A De C V Composicion para aerosol usada para marcar o delimitar en cualquier tipo de superficie con una duracion temporal.
JP6921913B2 (ja) * 2015-05-19 2021-08-18 チョーチアン オウスン ファーマシューティカル カンパニー リミテッド ネビボロールの合成方法及びその中間化合物
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) * 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475298A1 (fr) * 1980-02-01 1981-08-07 Thomson Csf Cellule photovoltaique et pile solaire utilisant une telle cellule
CA1337429C (en) 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
US4654362A (en) 1983-12-05 1987-03-31 Janssen Pharmaceutica, N.V. Derivatives of 2,2'-iminobisethanol
US6545040B1 (en) 1988-03-23 2003-04-08 Janssen Pharmaceutica N.V. Method of lowering the blood pressure
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
DE3809857A1 (de) 1988-03-24 1989-10-05 Philips Patentverwaltung Blasformmaschine zum blasformen von hohlkoerpern mit polsterregelung
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
HU227236B1 (en) * 2002-11-06 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag New process for the production of racemic and the pure [2s[2r*[r[r*]]]]-and [2r[2s*[s[s*]]]]-enantiomers of nebivolol
MX2007000911A (es) 2004-07-30 2007-04-12 Torrent Pharmaceuticals Ltd Nevibolol y sus sales farmaceuticamente aceptables, proceso para su preparacion y composiciones farmaceuticas de nevibolol.
UA87155C2 (ru) 2004-08-13 2009-06-25 Хардор Меканизм Продакшн Лтд Машина для обёртывание профилей
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
WO2007041805A1 (en) 2005-10-13 2007-04-19 Burns Bay Investments Pty Ltd Elongate lighting means
EP1803716B1 (en) 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1973895A1 (en) 2006-01-18 2008-10-01 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
PL2228374T3 (pl) 2006-11-27 2013-11-29 Zach System Spa Mrówczan nebiwololu
PT2102196E (pt) 2006-11-27 2012-10-31 Zach System Spa Processo para a preparação de nebivolol
CN101235024A (zh) * 2008-02-01 2008-08-06 中国科学院上海有机化学研究所 一类苯并二氢吡喃类化合物、合成方法和用途

Also Published As

Publication number Publication date
ZA201206221B (en) 2014-01-29
CN102858759A (zh) 2013-01-02
AU2011214396B2 (en) 2014-06-05
US8487122B2 (en) 2013-07-16
PL2534142T3 (pl) 2014-05-30
PT2534142E (pt) 2014-02-24
KR101726468B1 (ko) 2017-04-12
RS53134B (en) 2014-06-30
ITRM20100053A1 (it) 2011-08-12
JP2013519647A (ja) 2013-05-30
CA2786833A1 (en) 2011-08-18
AR080149A1 (es) 2012-03-14
US20120316351A1 (en) 2012-12-13
EP2534142A1 (en) 2012-12-19
KR20120129952A (ko) 2012-11-28
IL220846A (en) 2014-12-31
MX2012009386A (es) 2012-09-12
WO2011098474A1 (en) 2011-08-18
BR112012020252B1 (pt) 2021-05-04
CN102858759B (zh) 2015-12-16
CA2786833C (en) 2017-03-07
BR112012020252A2 (pt) 2016-08-09
ES2445543T3 (es) 2014-03-03
IT1397962B1 (it) 2013-02-04
IL220846A0 (en) 2012-08-30
EA201201127A1 (ru) 2013-01-30
SG183266A1 (en) 2012-09-27
EP2534142B1 (en) 2013-11-27
HRP20140155T1 (hr) 2014-03-14
AU2011214396A1 (en) 2012-10-04
EA019691B1 (ru) 2014-05-30
JP5698266B2 (ja) 2015-04-08
BR112012020252B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
ZA201202504B (en) Process for the preparation of calcobutrol
IL220523A0 (en) New process for the preparation of dronedarone
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
GB201004876D0 (en) Process for the preparation of vitamin K2
HK1179626A1 (en) Process for the preparation of nebivolol
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
IL226153A (en) Process for making nebibolol
IL225754A0 (en) Processes for the preparation of lubiprostone
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL221184A (en) A process for preparing 1-alkylated tetrazole 5 is produced
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
EP2571836A4 (en) PROCESS FOR PRODUCING HEXAFLUORO-2-BUTYNE
PL2593423T3 (pl) Proces wytwarzania środków kontrastowych
PT2390246T (pt) Processo para a preparação de aminaftona
PT2598504E (pt) Novo processo de fabrico de dimiracetam
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
IL224304A (en) A process for making dichlorobulben
ZA201208583B (en) Process for the preparation of hydroquinones
IL220160A (en) A process for the preparation of defrasirox
ZA201209050B (en) Process for the preparation of dihydropyrrole derivatives
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
PL390812A1 (pl) Sposób otrzymywania glicydolu
PL390811A1 (pl) Sposób otrzymywania glicydolu